Escalating regulation of 5T4-specific IFN-γ(+) CD4(+) T cells distinguishes colorectal cancer patients from healthy controls and provides a target for in vivo therapy.
about
Understanding Immune Cells in Tertiary Lymphoid Organ Development: It Is All Starting to Come TogetherMonitoring of the Immune Dysfunction in Cancer PatientsImmunotherapy of Metastatic Colorectal Cancer: Prevailing Challenges and New Perspectives.Boosting the MHC Class II-Restricted Tumor Antigen Presentation to CD4+ T Helper Cells: A Critical Issue for Triggering Protective Immunity and Re-Orienting the Tumor Microenvironment Toward an Anti-Tumor State.Low-dose cyclophosphamide induces anti-tumor T-cell responses which associate with survival in metastatic colorectal cancer.Tertiary Lymphoid Structures in Cancer: Drivers of Antitumor Immunity, Immunosuppression, or Bystander Sentinels in Disease?
P2860
Escalating regulation of 5T4-specific IFN-γ(+) CD4(+) T cells distinguishes colorectal cancer patients from healthy controls and provides a target for in vivo therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Escalating regulation of 5T4-specific IFN-γ
@nl
Escalating regulation of 5T4-s ...... a target for in vivo therapy.
@en
type
label
Escalating regulation of 5T4-specific IFN-γ
@nl
Escalating regulation of 5T4-s ...... a target for in vivo therapy.
@en
prefLabel
Escalating regulation of 5T4-specific IFN-γ
@nl
Escalating regulation of 5T4-s ...... a target for in vivo therapy.
@en
P2093
P2860
P1476
Escalating regulation of 5T4-s ...... s a target for in vivo therapy
@en
P2093
Adam Christian
Andrew Godkin
Anja Bloom
Awen Gallimore
Clare Brown
Hayley Bridgeman
Kathryn Smart
Mike Davies
Rachel Hargest
Rohit Srinivasan
P2860
P356
10.1158/2326-6066.CIR-13-0035
P577
2013-12-01T00:00:00Z